• Home
  • About Us
    Return
    • Company Profile
    • Development History
    • Quality System
    • Qualification honor
    • Company culture
    • Leader's speech
    • Watching Scinovo in VR
  • Platform Introduction
    Return
    • Mass Spectrometry Platform
    • Immunoassay Platform
    • Cell Biology Platform
    • Molecular Biology Platform
    • Pathology Platform
  • R & D Services
    Return
    • Nonclinical pharmacokinetics
    • Clinical pharmacokinetics
    • Bioanalysis
    • Biomarkers and pharmacodynamics
    • Pathological Diagnosis Service
    • Pharmacometrics Studies
    • Central Laboratory Services
  • Customer Center
    Return
    • Service Process
    • Service Features
    • Partner
    • Case Studies
    • Cooperative consultation
  • News and Trends
    Return
    • Company News
    • Industry News
  • Scinovo Academy
    Return
    • Bioanalysis Column
    • Academic Conference
    • Scinovo Courses
    • Scinovo Forum
  • Join Us
    Return
    • Talents wanted
    • Contact details
中文|English
Search
Scinovo Academy
  • Bioanalysis Column
  • Academic Conference
  • Scinovo Courses
  • Scinovo Forum
Your Current Position:  Scinovo Academy
  • The share of classic cases of pre-test results prompting post test
    2020-05-13
    The share of classic cases of pre-test results prompting post test
  • Regulatory requirement of FDA and CFDA for traceability related bioanalysis electronic data collection, backup, security and electronic signature
    2020-05-13
    Regulatory requirement of FDA and CFDA for traceability related bioanalysis electronic data collection, backup, security and electronic signature
  • The inspection and verification points of bioanalysis in BE studies under the new situation
    2020-05-13
    The inspection and verification points of bioanalysis in BE studies under the new situation
  • Bioanalysis strategy and application of endogenous substances
    2020-05-13
    Bioanalysis strategy and application of endogenous substances
  • The share of cases and method developments of new drug and drug which is difficult to detect in vivo
    2020-05-13
    The share of cases and method developments of new drug and drug which is difficult to detect in vivo
  • Quality management requirements of FDA and CFDA for bioanalysis laboratories
    2020-05-13
    Quality management requirements of FDA and CFDA for bioanalysis laboratories
First <Previous 1 2 Next> End

Home
About us
Platform Introduction
R&D 

Customer Center
News and Trends
Scinovo Academy
Contact us

Beijing Scinovo Laboratories Ltd. 

Address: 3rd Floor, Building 2, Jinweikai Technology Park, No. 8,Haiying Road, Science City, Fengtai District, Beijing,China
Postcode: 100070
Phone: +86-10-83611820
Mailbox: ygbd@bjscinovo.com


Follow us


Copyright © Beijing Scinovo Laboratories Ltd. All rights reserved Record number: Beijing ICP No. 17066146
京ICP备17066146号-1